Differentiated rhabdomyomatous tumors after chemotherapy for metastatic testicular germ-cell tumors: A clinicopathological study of seven cases mandating separation from rhabdomyosarcoma

Jessica A. Clevenger, Richard S. Foster, Thomas M. Ulbright

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

To gain insight concerning prognosis, we investigated seven cases of post-chemotherapy retroperitoneal lymph-node dissections from patients with testicular germ-cell tumors that contained sizable nodules of differentiated skeletal muscle, but that lacked both a primitive cellular component and mitotic activity. The patients were 18-28 years old at the time of retroperitoneal lymph-node dissection. All had a previous non-seminomatous germ-cell tumor of the testis, five of which had a teratoma component. In one the testicular tumor had foci of embryonal rhabdomyosarcoma. The retroperitoneal lymph-node dissections were performed 0.2-4.7 years after orchiectomy, all following cisplatin-based chemotherapy, and contained rhabdomyomatous tumors that ranged from 0.8-5 cm. These consisted of nodular to diffuse aggregates of fetal-type rhabdomyocytes with central to peripheral nuclei and abundant, eosinophilic, fibrillary cytoplasm with occasional cross striations. Elongated myotubes with multiple nuclei in a common sarcoplasm occurred at least focally in all cases. Mild to moderate nuclear atypia, including nuclear enlargement and nucleolar prominence, was present, but mitotic activity, necrosis, and a primitive cellular component were absent. All but one retroperitoneal lymph-node dissection also contained other teratomatous elements. Follow-up in six patients showed three were disease free at 2.2-3.4 years; two developed recurrent teratoma at 1.3-3.7 years; and a sixth developed recurrent teratoma at 0.5 and 2 years, followed at 17 years by progressive tumor with elevated α-fetoprotein. No patient with available follow-up developed progressive sarcoma. We conclude that rhabdomyomatous tumors in retroperitoneal lymph-node dissection specimens after chemotherapy for metastatic testicular germ-cell tumors show clinical behavior similar to teratoma rather than rhabdomyosarcoma. We believe the most likely explanation for the finding of pure rhabdomyomatous tumors in this setting, a phenomenon sometimes termed cytodifferentiation, is selective persistence of differentiated tumor cells because of chemotherapy.

Original languageEnglish (US)
Pages (from-to)1361-1366
Number of pages6
JournalModern Pathology
Volume22
Issue number10
DOIs
StatePublished - Oct 1 2009

Fingerprint

Rhabdomyosarcoma
Lymph Node Excision
Teratoma
Drug Therapy
Neoplasms
Embryonal Rhabdomyosarcoma
Fetal Proteins
Orchiectomy
Skeletal Muscle Fibers
Testicular Neoplasms
Sarcoma
Cisplatin
Testis
Cytoplasm
Skeletal Muscle
Necrosis
Testicular Germ Cell Tumor

Keywords

  • Retroperitoneum
  • Rhabdomyomatous tumor
  • Rhabdomyosarcoma
  • Teratoma
  • Testicular germ-cell tumor

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

@article{19840f318de2494c8fa7173c0bbf3470,
title = "Differentiated rhabdomyomatous tumors after chemotherapy for metastatic testicular germ-cell tumors: A clinicopathological study of seven cases mandating separation from rhabdomyosarcoma",
abstract = "To gain insight concerning prognosis, we investigated seven cases of post-chemotherapy retroperitoneal lymph-node dissections from patients with testicular germ-cell tumors that contained sizable nodules of differentiated skeletal muscle, but that lacked both a primitive cellular component and mitotic activity. The patients were 18-28 years old at the time of retroperitoneal lymph-node dissection. All had a previous non-seminomatous germ-cell tumor of the testis, five of which had a teratoma component. In one the testicular tumor had foci of embryonal rhabdomyosarcoma. The retroperitoneal lymph-node dissections were performed 0.2-4.7 years after orchiectomy, all following cisplatin-based chemotherapy, and contained rhabdomyomatous tumors that ranged from 0.8-5 cm. These consisted of nodular to diffuse aggregates of fetal-type rhabdomyocytes with central to peripheral nuclei and abundant, eosinophilic, fibrillary cytoplasm with occasional cross striations. Elongated myotubes with multiple nuclei in a common sarcoplasm occurred at least focally in all cases. Mild to moderate nuclear atypia, including nuclear enlargement and nucleolar prominence, was present, but mitotic activity, necrosis, and a primitive cellular component were absent. All but one retroperitoneal lymph-node dissection also contained other teratomatous elements. Follow-up in six patients showed three were disease free at 2.2-3.4 years; two developed recurrent teratoma at 1.3-3.7 years; and a sixth developed recurrent teratoma at 0.5 and 2 years, followed at 17 years by progressive tumor with elevated α-fetoprotein. No patient with available follow-up developed progressive sarcoma. We conclude that rhabdomyomatous tumors in retroperitoneal lymph-node dissection specimens after chemotherapy for metastatic testicular germ-cell tumors show clinical behavior similar to teratoma rather than rhabdomyosarcoma. We believe the most likely explanation for the finding of pure rhabdomyomatous tumors in this setting, a phenomenon sometimes termed cytodifferentiation, is selective persistence of differentiated tumor cells because of chemotherapy.",
keywords = "Retroperitoneum, Rhabdomyomatous tumor, Rhabdomyosarcoma, Teratoma, Testicular germ-cell tumor",
author = "Clevenger, {Jessica A.} and Foster, {Richard S.} and Ulbright, {Thomas M.}",
year = "2009",
month = "10",
day = "1",
doi = "10.1038/modpathol.2009.108",
language = "English (US)",
volume = "22",
pages = "1361--1366",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Differentiated rhabdomyomatous tumors after chemotherapy for metastatic testicular germ-cell tumors

T2 - A clinicopathological study of seven cases mandating separation from rhabdomyosarcoma

AU - Clevenger, Jessica A.

AU - Foster, Richard S.

AU - Ulbright, Thomas M.

PY - 2009/10/1

Y1 - 2009/10/1

N2 - To gain insight concerning prognosis, we investigated seven cases of post-chemotherapy retroperitoneal lymph-node dissections from patients with testicular germ-cell tumors that contained sizable nodules of differentiated skeletal muscle, but that lacked both a primitive cellular component and mitotic activity. The patients were 18-28 years old at the time of retroperitoneal lymph-node dissection. All had a previous non-seminomatous germ-cell tumor of the testis, five of which had a teratoma component. In one the testicular tumor had foci of embryonal rhabdomyosarcoma. The retroperitoneal lymph-node dissections were performed 0.2-4.7 years after orchiectomy, all following cisplatin-based chemotherapy, and contained rhabdomyomatous tumors that ranged from 0.8-5 cm. These consisted of nodular to diffuse aggregates of fetal-type rhabdomyocytes with central to peripheral nuclei and abundant, eosinophilic, fibrillary cytoplasm with occasional cross striations. Elongated myotubes with multiple nuclei in a common sarcoplasm occurred at least focally in all cases. Mild to moderate nuclear atypia, including nuclear enlargement and nucleolar prominence, was present, but mitotic activity, necrosis, and a primitive cellular component were absent. All but one retroperitoneal lymph-node dissection also contained other teratomatous elements. Follow-up in six patients showed three were disease free at 2.2-3.4 years; two developed recurrent teratoma at 1.3-3.7 years; and a sixth developed recurrent teratoma at 0.5 and 2 years, followed at 17 years by progressive tumor with elevated α-fetoprotein. No patient with available follow-up developed progressive sarcoma. We conclude that rhabdomyomatous tumors in retroperitoneal lymph-node dissection specimens after chemotherapy for metastatic testicular germ-cell tumors show clinical behavior similar to teratoma rather than rhabdomyosarcoma. We believe the most likely explanation for the finding of pure rhabdomyomatous tumors in this setting, a phenomenon sometimes termed cytodifferentiation, is selective persistence of differentiated tumor cells because of chemotherapy.

AB - To gain insight concerning prognosis, we investigated seven cases of post-chemotherapy retroperitoneal lymph-node dissections from patients with testicular germ-cell tumors that contained sizable nodules of differentiated skeletal muscle, but that lacked both a primitive cellular component and mitotic activity. The patients were 18-28 years old at the time of retroperitoneal lymph-node dissection. All had a previous non-seminomatous germ-cell tumor of the testis, five of which had a teratoma component. In one the testicular tumor had foci of embryonal rhabdomyosarcoma. The retroperitoneal lymph-node dissections were performed 0.2-4.7 years after orchiectomy, all following cisplatin-based chemotherapy, and contained rhabdomyomatous tumors that ranged from 0.8-5 cm. These consisted of nodular to diffuse aggregates of fetal-type rhabdomyocytes with central to peripheral nuclei and abundant, eosinophilic, fibrillary cytoplasm with occasional cross striations. Elongated myotubes with multiple nuclei in a common sarcoplasm occurred at least focally in all cases. Mild to moderate nuclear atypia, including nuclear enlargement and nucleolar prominence, was present, but mitotic activity, necrosis, and a primitive cellular component were absent. All but one retroperitoneal lymph-node dissection also contained other teratomatous elements. Follow-up in six patients showed three were disease free at 2.2-3.4 years; two developed recurrent teratoma at 1.3-3.7 years; and a sixth developed recurrent teratoma at 0.5 and 2 years, followed at 17 years by progressive tumor with elevated α-fetoprotein. No patient with available follow-up developed progressive sarcoma. We conclude that rhabdomyomatous tumors in retroperitoneal lymph-node dissection specimens after chemotherapy for metastatic testicular germ-cell tumors show clinical behavior similar to teratoma rather than rhabdomyosarcoma. We believe the most likely explanation for the finding of pure rhabdomyomatous tumors in this setting, a phenomenon sometimes termed cytodifferentiation, is selective persistence of differentiated tumor cells because of chemotherapy.

KW - Retroperitoneum

KW - Rhabdomyomatous tumor

KW - Rhabdomyosarcoma

KW - Teratoma

KW - Testicular germ-cell tumor

UR - http://www.scopus.com/inward/record.url?scp=70349659676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349659676&partnerID=8YFLogxK

U2 - 10.1038/modpathol.2009.108

DO - 10.1038/modpathol.2009.108

M3 - Article

C2 - 19633644

AN - SCOPUS:70349659676

VL - 22

SP - 1361

EP - 1366

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 10

ER -